table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 mild to moderateCOVID-19 severe or critically
anti-inflammatory therapies Malgorzata
anti GM-CSF
mavrilimumab MASH-COVID ...
clarithromycine Tsiakos Rashad ...
colchicine Scarsi GRECCO-19 Sandhu Lopes MIF Horby COLCOVID Salehzadeh RECOVERY ... COL-COVID ... COLCHIVID Brunetti
Colchicine plus rosuvastatin COLSTAT Gaitan-Duarte ...
non-steroidal anti-inflammatory drugs Jeong Bruce Imam Drake Guzman-Esquivel
Celecoxib Wenxin
Indomethacin Ravichandran Ravichandran
stem cells Carmenate ... Lanzoni Shu Shi
vilobelimab (IFX-1) PANAMO

0 studies excluded by filtering options 2

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons